PTPA and glioblastoma: NNMT was reported to be a prognostic marker for glioblastoma [31], inhibiting tumor suppressor protein phosphatase 2 (PP2A) at the epigenome and proteome level and concomitantly activates prosurvival serine/threonine kinases.